This study not only discovered a novel mechanism of ZBP1 in regulating IFN signaling independent of necrosis and apoptosis, but also provided a new therapeutic strategy for the clinical treatment of Aicardi–Goutières syndrome and other diseases caused by ADAR1 mutations. The gene discussed is ADAR; the disease is Aicardi-Goutieres syndrome.